Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PIRS crawled time : 12:00 save search
Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study
Published: 2023-06-21 (Crawled : 12:00) - biospace.com/
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: -58.66%
H: 5.38%
C: -29.51%
prs-060 pharmaceuticals trial study
Pieris Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Updates
Published: 2023-05-10 (Crawled : 12:00) - biospace.com/
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: -1.76%
H: 4.19%
C: 2.99%
business pharmaceuticals financial results
Pieris Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-02 (Crawled : 12:00) - biospace.com/
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: 0.94%
H: 5.61%
C: -4.67%
pharmaceuticals financial update results
Pieris Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: -2.2%
H: 1.12%
C: -3.37%
update results
Pieris Pharmaceuticals to Host Second Quarter 2022 Investor Call and Provide Corporate Update on August 4, 2022
Published: 2022-07-28 (Crawled : 12:00) - biospace.com/
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: -0.55%
H: 2.21%
C: -0.55%
update
Pieris Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-05-11 (Crawled : 12:00) - biospace.com/
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: -19.73%
results
Pieris Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-02 (Crawled : 12:00) - biospace.com/
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: 5.97%
H: 0.56%
C: -2.66%
financial results results
Abcuro Appoints Darlene Deptula-Hicks to its Board of Directors
Published: 2021-10-19 (Crawled : 12:00) - biospace.com/
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: 2.13%
H: 9.47%
C: 2.73%
TTOO A | $2.97 1.02% 1.01% 110K
|
Health Technology
|
| O: -0.52%
H: 3.92%
C: 3.21%
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: 1.37%
H: 1.8%
C: -0.68%
Pieris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: -0.55%
H: 3.59%
C: 0.83%
financial results results
Pieris Pharmaceuticals Announces Inhaled CTGF Inhibitor PRS-220 for Idiopathic Pulmonary Fibrosis and 17 Million Dollar Grant From Bavarian Government To Accelerate Program Development for Post-COVID-19 Pulmonary Fibrosis
Published: 2021-06-25 (Crawled : 12:00) - biospace.com/
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: 12.13%
H: 0.2%
C: -18.37%
covid fibrosis
Pieris Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: 1.6%
H: 6.81%
C: 0.52%
financial results results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.